Mr. Li is primarily responsible for the overall management, business, and strategy of our Group, as well as oversight of our Group's commercial suitability and sustainability. Prior to joining our Group, Mr. Li was the deputy general manager at Hainan Development Construction General Company, the general manager at Hainan Real Estate Development General Company and the deputy director at the State-owned Assets Management Office of Hainan Province. Mr. Li entered Peking University and was send to RWTH Aachen University in Germany to continue his engineering master and obtained degree at public expense.

Mr. Lian is primarily responsible for our Group's overall management and overall strategy including decision-making on major matters. Mr. Lian has twenty years' experience in the aesthetic medical industry. Prior to joining our Group, Mr. Lian founded Juva Medical (Tianjin) Technology Co., Ltd. and was acquired by Haohai Biology Technology (HKEX: 06826; SSE STAR: 688366) in 2021. He previously served as deputy general manager at Henan Plastic Surgery Hospital Co., Ltd. and the general manager at Beijing Mansimei Medical Technology Co., Ltd. Mr. Lian obtained his master of business administration degree from Tsinghua University.

Mr. Hu was appointed as a non-executive Director in August 2024. He is primarily responsible for formulating the Company's strategies and overseeing its operations and development. Mr. Hu has served as the managing director of the Consumer Research and Investment Department at CPE since 2008. He has accumulated over 20 years of practical experience in capital markets and investment. Prior to his involvement in private equity, Mr. Hu had 11 years of experience in the securities industry, including a role as an executive director at CITIC Securities Company Limited, where he presided over the issuance and sponsorship of stocks, corporate bonds, convertible bonds and funds. Mr. Hu holds a bachelor’s degree in philosophy from Hangzhou University (now Zhejiang University), a master’s degree in economics from Renmin University of China, and an executive MBA from the China Europe International Business School.

Mr. Geng joined our Group in December 2013, and was subsequently appointed as a Director in February 2022. He was redesignated as a non-executive Director in March 2022. Mr. Geng is primarily responsible for decision-making with respect to major matters such as formulating overall strategies, hiring Company executives, and advancing mergers and acquisitions, as well as managing corporate financing. Mr. Geng is investment director of Beijing Pan Mao Investment Management Co., Ltd., bringing over 20 years of experience in the investment and management industry. Mr. Geng also serves as non-executive director of Yonghe Medical (HKEX:2279). Mr. Geng previously served as management positions for multiple companies, include director of Wangfujing Group (SSE:600859). Mr. Geng obtained his master’s degree in business administration from the State University of New Jersey, the U.S., and his bachelor’s degree in accounting & finance and business administration & management from Oxford Brookes University, the United Kingdom.

Ms. Li joined our Group as a business manager in May 2016. She was appointed as a Director in February 2022 and was redesignated as a non-executive Director in March 2022. She is primarily responsible for the overall management, business, and strategy of our Group and oversight of the commercial suitability and sustainability of our Group. Ms. Li obtained her a Bachelor of Science degree with a major in management from the London School of Economics and Political Science in London, United Kingdom in July 2012.

Mr. Fan was appointed as an independent non-executive Director of the Company in January 2023 and is primarily responsible for supervising and providing independent advice to our Board. Mr. Fan has over 15 years of experience in arbitration and management. Mr. Fan currently serves as the Executive Vice President of the Shanghai Arbitration Commission, Council Member of China Commission of Arbitration for Sport and arbitrator of the Court of Arbitration for Sports. Prior to joining our Group, Mr. Fan worked as a lecturer and an associate professor for over 10 years, and served as the Deputy Director of the International Affairs Office at Shanghai University of Political Science and Law, the Director of Arbitration and ADR for North Asia of the International Chamber of Commerce, and the Chief Representative of its Shanghai Representative Office. Mr. Fan obtained his doctorate and bachelor’s degrees in international law from East China University of Politics and Law in Shanghai, and his master’s degree in international commercial law from the University of Manchester in the United Kingdom.

Mr. Liu was appointed as an independent non-executive Director of the Company in January 2023 and is primarily responsible for supervising and providing independent advice to our Board. With extensive experience in financial management and investment banking, Mr. Liu serves as xx of xx, the chairman and SFC licensed responsible officer at China Eagle Asset Management Limited, and an independent non-executive director at Raily Aesthetic Medicine International Holdings, a medical beauty company listed on the Hong Kong Stock Exchange (HKEX: 2135), where he is the chairman of the audit committee and a member of the remuneration committee. Management positions at asset management companies held by Mr. Liu include acting CEO of China Universal Asset Management (Hong Kong) Company Limited, and executive director at China Orient International Asset Management Limited. Mr. Liu obtained his master’s degree in professional accounting and information systems from the City University of Hong Kong. He is an admitted member of the Association of Chartered Certified Accountants and a certified public accountant of Hong Kong Institute of Certified Public Accountants.

Mr. Jiang was appointed as an independent non-executive Director of the Company in January 2023 and is primarily responsible for supervising and providing independent advice to our Board. Mr. Jiang has over 30 years of experience in academics and plastic surgery, and he currently serves as the chief physician and professor at Shanghai East Hospital. Prior to joining the Group, he was the director of plastic surgery at The Second Affiliated Hospital of the Second Military Medical University (currently known as Shanghai Changzheng Hospital). Mr. Jiang received his postgraduate degree in medicine from the National University of Singapore, and his bachelor’s degree in clinical medicine from the Second Military Medical University of the Chinese People’s Liberation Army in Shanghai. Mr. Jiang is a certified surgeon of the People’s Liberation Army General Logistics Department.